L. Abramowitz, A. Jacquard, F. Jaroud, J. Haesebaert, L. Siproudhis et al., Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study, International Journal of Cancer, vol.20, issue.Suppl 10, pp.433-439, 2010.
DOI : 10.1002/ijc.25671
URL : https://hal.archives-ouvertes.fr/hal-00563122

L. Abramowitz, R. V. Vainchtock, and A. , Economic burden of anal cancer management in France, Revue d'??pid??miologie et de Sant?? Publique, vol.58, issue.5, pp.331-338, 2010.
DOI : 10.1016/j.respe.2010.06.165

N. Bajos, M. Bozon, and N. Beltzer, French National Survey on sexual behavior, 2008.

S. Blödt, J. Müller-nordhorn, and N. Rieckmann, Human Papillomavirus awareness, knowledge and vaccine acceptance: A survey among 18-25 year old male and female vocational school students in Berlin, Germany, The European Journal of Public Health, vol.22, issue.6, 2011.
DOI : 10.1093/eurpub/ckr188

D. Brewster and L. Bhatti, Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975???2002, British Journal of Cancer, vol.31, issue.1, pp.87-90, 1975.
DOI : 10.1023/B:CACO.0000003837.10664.7f

X. Castellsague, N. Munoz, P. Pitisuttithum, D. Ferris, J. Monsonego et al., End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24???45 years of age, British Journal of Cancer, vol.356, issue.1, pp.28-37, 2011.
DOI : 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.3.CO;2-6

M. Castor, D. Silva, H. , G. Martins, D. et al., HPV and precancerous lesions of anal canal in women: systematic review, International Journal of Colorectal Disease, vol.93, issue.11, pp.271-276, 2011.
DOI : 10.1007/s00384-011-1298-1

E. Dasbach, E. Elbasha, and R. Insinga, Mathematical Models for Predicting the Epidemiologic and Economic Impact of Vaccination against Human Papillomavirus Infection and Disease, Epidemiologic Reviews, vol.28, issue.1, pp.88-100, 2006.
DOI : 10.1093/epirev/mxj006

E. Elbasha and E. Dasbach, Impact of vaccinating boys and men against HPV in the United States, Vaccine, vol.28, issue.42, pp.6858-6867, 2010.
DOI : 10.1016/j.vaccine.2010.08.030

E. Elbasha, E. Dasbach, and R. Insinga, Model for Assessing Human Papillomavirus Vaccination Strategies, Emerging Infectious Diseases, vol.13, issue.1, pp.28-41, 2007.
DOI : 10.3201/eid1301.060438

J. Fagot, A. Boutrelle, P. Ricordeau, A. Weill, and H. Allemand, HPV vaccination in France: Uptake, costs and issues for the National Health Insurance, Vaccine, vol.29, issue.19, pp.29-3610, 2011.
DOI : 10.1016/j.vaccine.2011.02.064

G. Garnett and R. Anderson, Contact Tracing and the Estimation of Sexual Mixing Patterns, Sexually Transmitted Diseases, vol.20, issue.4, pp.181-191, 1993.
DOI : 10.1097/00007435-199307000-00001

A. Giuliano, J. Palefsky, S. Goldstone, E. Moreira, . Jr et al., Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males, New England Journal of Medicine, vol.364, issue.5, pp.401-411, 2011.
DOI : 10.1056/NEJMoa0909537

S. Goldie, D. Grima, M. Kohli, T. Wright, M. Weinstein et al., A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine, International Journal of Cancer, vol.9, issue.6, pp.896-904, 2003.
DOI : 10.1002/ijc.11334

S. Goldie, M. Kohli, D. Grima, M. Weinstein, T. Wright et al., Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine, JNCI Journal of the National Cancer Institute, vol.96, issue.8, pp.96-604, 2004.
DOI : 10.1093/jnci/djh104

M. Goodman, B. Hernandez, X. Wilkens, P. Thompson, J. Killeen et al., The Influence of Multiple Human Papillomavirus Types on the Risk of Genotype-Concordant Incident Infections of the Anus and Cervix: The Hawaii HPV Cohort Study, Journal of Infectious Diseases, vol.203, issue.3, p.335, 2010.
DOI : 10.1093/infdis/jiq058

B. Hernandez, K. Mcduffie, X. Zhu, L. Wilkens, J. Killeen et al., Anal Human Papillomavirus Infection in Women and Its Relationship with Cervical Infection, Cancer Epidemiology Biomarkers & Prevention, vol.14, issue.11, pp.14-2550, 2005.
DOI : 10.1158/1055-9965.EPI-05-0460

H. Hethcote, An age-structured model for pertussis transmission, Mathematical Biosciences, vol.145, issue.2, pp.89-136, 1997.
DOI : 10.1016/S0025-5564(97)00014-X

R. Hillman, A. Giuliano, J. Palefsky, S. Goldstone, E. Moreira et al., Immunogenicity of the quadrivalent human papillomavirus, Vaccine Immunol, vol.111618, issue.192, pp.261-267, 2011.

C. Hughes, A. Jones, K. Feemster, and A. Fiks, HPV vaccine decision making in pediatric primary care: a semi-structured interview study, BMC Pediatrics, vol.39, issue.1, p.74, 2011.
DOI : 10.1080/00224490209552116

F. Jin, A. Stein, E. Conway, D. Regan, M. Law et al., Trends in anal cancer in Australia, Vaccine, issue.12, pp.29-2322, 1982.

M. Jit, R. Chapman, O. Hughes, and Y. Choi, Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model, BMJ, vol.343, issue.sep27 1, p.5775, 2011.
DOI : 10.1136/bmj.d5775

J. Kim, Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis, The Lancet Infectious Diseases, vol.10, issue.12, pp.845-852, 2010.
DOI : 10.1016/S1473-3099(10)70219-X

A. Kreimer, P. Gonzalez, H. Katki, C. Porras, M. Schiffman et al., Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial, The Lancet Oncology, vol.12, issue.9, pp.862-870, 2011.
DOI : 10.1016/S1470-2045(11)70213-3

S. Kulasingam and E. Myers, Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs, JAMA, vol.290, issue.6, pp.781-789, 2003.
DOI : 10.1001/jama.290.6.781

D. Lutringer-magnin, G. Barone, H. Borne, V. Regnier, P. Vanhems et al., [Gynaecologists' attitudes and practices towards HPV vaccination: a quantitative-qualitative study in Rhône- Alpes], Gynecol. Obstet. Fertil, issue.12, pp.39-687, 2011.

N. Muñoz, M. Jr, R. Pitisuttithum, P. Tresukosol, D. Monsonego et al., Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: A randomised, double-blind trial, Lancet, National Institute of Cancer, vol.373, pp.1949-1957, 2009.

E. Myers, D. Mccrory, K. Nanda, L. Bastian, and D. Matchar, Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis, American Journal of Epidemiology, vol.151, issue.12, pp.1158-1171, 2000.
DOI : 10.1093/oxfordjournals.aje.a010166

A. Nielsen, C. Munk, and S. Kjaer, Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008, International Journal of Cancer, vol.124, issue.10 Suppl, pp.1168-1173, 1978.
DOI : 10.1002/ijc.26115

C. Nielson, R. Harris, R. Flores, M. Abrahamsen, M. Papenfuss et al., Multiple-Type Human Papillomavirus Infection in Male Anogenital Sites: Prevalence and Associated Factors, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.4, pp.1077-1083, 2009.
DOI : 10.1158/1055-9965.EPI-08-0447

H. Kitchener, X. Castellsague, J. Teixeira, S. Skinner, J. Hedrick et al., Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women, Lancet, issue.9686, pp.374-301, 2009.

J. Palefsky, E. Holly, C. Hogeboom, M. Ralston, M. Dacosta et al., Virologic, Immunologic, and Clinical Parameters in the Incidence and Progression of Anal Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Homosexual Men, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.17, issue.4, pp.314-319, 1998.
DOI : 10.1097/00042560-199804010-00004

L. Rambout, L. Hopkins, B. Hutton, and D. Fergusson, Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials, Canadian Medical Association Journal, vol.177, issue.5, pp.469-479, 2007.
DOI : 10.1503/cmaj.070948

L. Ribassin-majed, R. Lounes, and S. Clemencon, Efficacy of Vaccination against HPV Infections to Prevent Cervical Cancer in France: Present Assessment and Pathways to Improve Vaccination Policies, PLoS ONE, vol.29, issue.3, 2012.
DOI : 10.1371/journal.pone.0032251.s014
URL : https://hal.archives-ouvertes.fr/hal-00678652

A. Taira, C. Neukermans, and G. Sanders, Evaluating Human Papillomavirus Vaccination Programs, Emerging Infectious Diseases, vol.10, issue.11, pp.1915-1923, 2004.
DOI : 10.3201/eid1011.040222

N. Van-de-velde, M. Brisson, and M. Boily, Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis, Vaccine, vol.28, issue.33, pp.28-5473, 2010.
DOI : 10.1016/j.vaccine.2010.05.056